Q4 Earnings Estimate for USNA Issued By DA Davidson

USANA Health Sciences, Inc. (NYSE:USNA) – Equities research analysts at DA Davidson issued their Q4 2024 earnings per share estimates for USANA Health Sciences in a report issued on Wednesday, October 23rd. DA Davidson analyst L. Weiser expects that the company will post earnings per share of $0.49 for the quarter. DA Davidson currently has a “Neutral” rating and a $35.00 target price on the stock. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.50 per share.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, October 22nd. The company reported $0.56 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.07. The company had revenue of $200.22 million during the quarter, compared to analyst estimates of $208.45 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.80%. During the same quarter last year, the business posted $0.59 EPS.

Separately, StockNews.com lowered USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 24th.

USANA Health Sciences Stock Performance

USANA Health Sciences stock opened at $37.81 on Friday. The company has a market capitalization of $720.28 million, a PE ratio of 13.36, a P/E/G ratio of 1.15 and a beta of 0.89. The company has a 50 day moving average price of $37.96 and a 200-day moving average price of $42.51. USANA Health Sciences has a fifty-two week low of $34.15 and a fifty-two week high of $54.81.

Insider Activity

In other news, insider Paul A. Jones sold 6,266 shares of the stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total transaction of $240,489.08. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other USANA Health Sciences news, Director John Turman Fleming sold 1,000 shares of the business’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $44.43, for a total value of $44,430.00. Following the completion of the transaction, the director now directly owns 2,503 shares in the company, valued at approximately $111,208.29. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Paul A. Jones sold 6,266 shares of the stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total transaction of $240,489.08. The disclosure for this sale can be found here. In the last quarter, insiders sold 7,940 shares of company stock worth $311,670. 0.33% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of USNA. Assenagon Asset Management S.A. boosted its stake in USANA Health Sciences by 13.5% in the third quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock valued at $4,702,000 after acquiring an additional 14,756 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its position in shares of USANA Health Sciences by 14,068.2% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock worth $1,472,000 after purchasing an additional 38,547 shares in the last quarter. Creative Planning purchased a new position in USANA Health Sciences during the 3rd quarter worth $394,000. Exchange Traded Concepts LLC increased its position in USANA Health Sciences by 4.4% during the 3rd quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company’s stock valued at $292,000 after buying an additional 322 shares in the last quarter. Finally, Unison Advisors LLC purchased a new stake in USANA Health Sciences in the third quarter valued at about $683,000. Institutional investors own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.